Intelligence Β· Clinical Pipeline
United Therapeutics Europe Pipeline
All ClinicalTrials.gov programs at United Therapeutics Europe β phase, modality, and trial IDs.
- Programs
- 184
Quick answer
United Therapeutics Europe has 184 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
UB-621
United Therapeutics Europe Ltd
Herpes Simplex Virus Infection
1 trial -
UB-921
United Therapeutics Europe Ltd
Breast Neoplasm
1 trial -
UI009
United Therapeutics Europe Ltd
Health
1 trial -
UI059
United Therapeutics Europe Ltd
GERD
1 trial -
UI059
United Therapeutics Europe Ltd
Gastro-Intestinal Disorder
1 trial -
UI15AML055MT
United Therapeutics Europe Ltd
Healthy
1 trial -
UIC201602 and co-administration of UIC201601 and UIC201602
United Therapeutics Europe Ltd
Healthy
1 trial -
UKidney
United Therapeutics Europe Ltd
Kidney Failure, Chronic
1 trial -
UNEX-42
United Therapeutics Europe Ltd
Bronchopulmonary Dysplasia
1 trial -
USB005 (aclerastide) Ophthalmic Solution
United Therapeutics Europe Ltd
Healthy Volunteers
1 trial -
UT-15C
United Therapeutics Europe Ltd
Healthy
2 trials -
UT-15C SR (treprostinil diethanolamine)
United Therapeutics Europe Ltd
Pulmonary Arterial Hypertension
1 trial -
V920
United Therapeutics Europe Ltd
Ebola Virus
1 trial -
VS-6766
United Therapeutics Europe Ltd
NSCLC
1 trial -
Vaccine/device combination for prevention of HFRS
United Therapeutics Europe Ltd
Hemorrhagic Fever With Renal Syndrome
1 trial -
Venezuelan Equine Encephalitis DNA Vaccine
United Therapeutics Europe Ltd
Vaccine Reaction
1 trial -
WX-UK1 in combination with Capecitabine
United Therapeutics Europe Ltd
Advanced Malignancies
1 trial -
[123I] IBVM and SPECT imaging
United Therapeutics Europe Ltd
Parkinson Disease
1 trial -
[18F]-Ξ±vΞ²6-BP
United Therapeutics Europe Ltd
Lung Cancer
1 trial -
acetylsalicylic acid
United Therapeutics Europe Ltd
Precancerous Condition
1 trial -
acupuncture
United Therapeutics Europe Ltd
Migraine Headaches
1 trial -
administration of UI018
United Therapeutics Europe Ltd
Hyperlipemia, Mixed
1 trial -
administration of UI058
United Therapeutics Europe Ltd
GERD
1 trial -
administration of UI068
United Therapeutics Europe Ltd
Diabetes Mellitus, Type 2
1 trial -
cNP8
United Therapeutics Europe Ltd
Burns
1 trial -
d-cycloserine
United Therapeutics Europe Ltd
Chronic Obstructive Pulmonary Disease
1 trial -
engineered autologous T cells
United Therapeutics Europe Ltd
Prostate Cancer
1 trial -
hypo-fractionated SRS
United Therapeutics Europe Ltd
Metastatic Cancer
1 trial -
iC9.GD2.CAR.IL-15 T Infusion
United Therapeutics Europe Ltd
Lung Cancer
1 trial -
iC9.GD2.CAR.IL-15 T-cells
United Therapeutics Europe Ltd
Neuroblastoma
1 trial -
iNexinβ’ (0.08% aCT1)
United Therapeutics Europe Ltd
Dry Eye Disease
1 trial -
limonene containing massage oil
United Therapeutics Europe Ltd
Breast Cancer
1 trial -
milatuzumab
United Therapeutics Europe Ltd
Lupus Erythematosus, Cutaneous
1 trial -
olaparib
United Therapeutics Europe Ltd
Advanced Cancer
1 trial -
oral treprostinil
United Therapeutics Europe Ltd
Raynaud's Phenomenon
1 trial -
pTVG-HP with rhGM-CSF
United Therapeutics Europe Ltd
Prostate Cancer
1 trial -
removal of omentum
United Therapeutics Europe Ltd
Diabetes Mellitus Type 2
1 trial -
treatment A
United Therapeutics Europe Ltd
Dyslipidemia
1 trial -
treprostinil diethanolamine
United Therapeutics Europe Ltd
Pulmonary Arterial Hypertension
2 trials -
zelenirstat
United Therapeutics Europe Ltd
Relapsed Adult AML
1 trial
Frequently asked questions
How many pipeline programs does United Therapeutics Europe have?
184 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources Β· All pipeline programs